Your browser doesn't support javascript.
loading
Masked malignant phenotype with a benign appearance: beat-up copy number profile may be the key for hemangioblastoma dissemination.
Oya, Soichi; Takayanagi, Shunsaku; Takami, Hirokazu; Indo, Masahiro; Yamashita, Takahisa; Saito, Nobuhito; Matsui, Toru.
Afiliação
  • Oya S; Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan. sooya-tky@umin.ac.jp.
  • Takayanagi S; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Takami H; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Indo M; Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
  • Yamashita T; Department of Pathology, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
  • Saito N; Department of Neurosurgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Matsui T; Department of Neurosurgery, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe, Saitama, 350-8550, Japan.
Brain Tumor Pathol ; 38(1): 71-77, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33073327
Dissemination of histologically benign hemangioblastoma is rare; approximately 30 cases have previously been reported, and all cases occurred several months to years after surgical resection. Herein, we report a case of hemangioblastoma in which leptomeningeal dissemination occurred 2 years after hypofractionated radiation therapy (39 Gy/13 fractions). The tumor was treated primarily with radiation without surgical resection. Biopsy of the disseminated lesion confirmed histological diagnosis as histologically benign hemangioblastoma. Ki67 index was not remarkably elevated for hemangioblastomas. In addition, the methylation class determined by the methylation profiling classifier developed by the German Cancer Research Center (DKFZ)/University Hospital Heidelberg/German Consortium for Translational Cancer Research was consistent with that of common hemangioblastomas. However, genetic analyses showed significant gains and losses throughout the whole genome, indicating that highly aberrant copy number profiles may be the key to elucidating this rare but life-threatening clinical entity. Accumulation of more detailed case reports based on the comparison of specimens obtained before and after surgery or radiation is necessary to better understand the pathophysiology of the dissemination phenotype of hemangioblastoma.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Neoplasias Cerebelares / Hemangioblastoma / Estudos de Associação Genética / Variações do Número de Cópias de DNA / Invasividade Neoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenótipo / Neoplasias Cerebelares / Hemangioblastoma / Estudos de Associação Genética / Variações do Número de Cópias de DNA / Invasividade Neoplásica Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article